Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Not Confirmed
Not Confirmed
08-10 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
08-11 September, 2025
ChemOutsourcingChemOutsourcing
Industry Trade Show
Not Confirmed
08-10 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-approvals-drop-24-in-h1-2025-gsk-s-uti-med-vertex-s-non-opioid-painkiller-lead-pack-of-first-in-class-meds
14 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/14/3133385/0/en/ZyVersa-Therapeutics-Highlights-Data-Demonstrating-a-Critical-Need-for-Therapies-to-Address-Kidney-Lipotoxicity-to-Alleviate-Diabetic-Kidney-Disease-DKD-and-Its-Progression.html
13 Aug 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/08/13/3132643/0/en/ZyVersa-Therapeutics-Reports-Second-Quarter-2025-Financial-Results-and-Highlights-Key-Near-term-Value-building-Milestones.html
21 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/21/3118650/0/en/ZyVersa-Therapeutics-CEO-Issues-Mid-year-Shareholder-Letter-Highlighting-Recent-Corporate-Developments-and-R-D-Progress.html
08 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/08/3112068/0/en/ZyVersa-Therapeutics-Announces-a-Warrant-Inducement-Transaction-for-2-0-Million-in-Gross-Proceeds.html
08 Jul 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/07/08/3111633/0/en/ZyVersa-Therapeutics-Supports-FDA-Authorized-Emergency-Compassionate-Use-of-Cholesterol-Efflux-Mediator-VAR-200-in-a-Patient-with-ApoCII-Amyloidosis.html
26 Jun 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/06/26/3105758/0/en/ZyVersa-Therapeutics-Announces-First-Clinical-Site-Activation-Initiating-Patient-Recruitment-for-Cholesterol-Efflux-Mediator-VAR-200-s-Phase-2a-Clinical-Trial-in-Patients-with-Diab.html
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE